Pathway of cytotoxicity induced by folic acid modified selenium nanoparticles in MCF-7 cells

Applied Microbiology and Biotechnology

Volumn 97, Issue 3, 2013, Pages 1051-1062

  Pi, Jiang ^a   Jin, Hua ^a   Liu, Ruiying ^a   Song, Bing ^a   Wu, Qing ^a   Liu, Li ^a   Jiang, Jinhuan ^a   Yang, Fen ^a   Cai, Huaihong ^a   Cai, Jiye ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Apoptosis; Endocytosis; Folate; MCF 7 cells; Selenium nanoparticles; Subcellular localization

Indexed keywords

ENDOCYTOSIS; FOLATE; MCF-7 CELLS; SELENIUM NANOPARTICLES; SUBCELLULAR LOCALIZATIONS;

CELL DEATH; CELL MEMBRANES; CYTOTOXICITY; MEDICAL APPLICATIONS; MOLECULAR BIOLOGY; NANOPARTICLES; ORGANIC ACIDS; SELENIUM; SPECTROSCOPIC ANALYSIS;

MITOCHONDRIA;

DRUG CARRIER; FOLATE RECEPTOR; FOLIC ACID; NANOPARTICLE; SELENIUM;

APOPTOSIS; BIOTECHNOLOGY; CANCER; DISEASE TREATMENT; DRUG; INHIBITION; MITOCHONDRION; NANOTECHNOLOGY; SELENIUM; TOXICITY TEST; VITAMIN;

ANIMAL CELL; ARTICLE; CANCER THERAPY; CELL CYCLE ARREST; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CYTOTOXICITY; ENDOCYTOSIS; ENDOSOME; IN VITRO STUDY; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL MEMBRANE; CELL SURVIVAL; CYTOSKELETON; ENDOCYTOSIS; FOLIC ACID; HUMANS; MCF-7 CELLS; MITOCHONDRIA; NANOPARTICLES; SELENIUM;

EID: 84874118583     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-012-4359-7     Document Type: Article

References (51)

1. Abdulah R, Miyazaki K, Nakazawa M, Koyama H (2005) Chemical forms of selenium for cancer prevention. J Trace Elem Med Biol 19:141-150
2. Adams JM (2003) Ways of dying: multiple pathways to apoptosis. Genes Dev 17:2481-2495
3. Chen TF, Wong YS, Zheng WJ, Bai Y, Huang L (2008) Selenium nanoparticles fabricated in Undaria pinnatifida polysaccharide solutions induce mitochondria-mediated apoptosis in A375 human melanoma cells. Colloid Surf B 67:26-31
4. Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116:205-219
5. Dustin ML (2006) When F-actin becomes too much of a good thing. Science 313:767-768
6. El-Bayoumy K, Sinha R (2004) Mechanisms of mammary cancer chemoprevention by organoselenium compounds. Mutat Res 551:181-197
7. Elnakat H, Ratnam M (2006) Role of folate receptor genes in reproduction and related cancers. Front Biosci 11:506-519
8. Evans CW, Fitzgerald M, Clemons TD, House MJ, Padman BS, Shaw JA, Saunders M, Harvey AR, Zdyrko B, Luzinov I, Silva GA, Dunlop SA, Iyer KS (2011) Multimodal analysis of PEI-mediated endocytosis of nanoparticles in neural cells. ACS Nano 5:8640-8648
9. Fang WF, Han AJ, Bi XL, Xiong B, Yang WC (2010) Tumor inhibition by sodium selenite is associated with activation of c-Jun NH2-terminal kinase 1 and suppression of β-catenin signaling. Int J Cancer 127:32-42
10. Grimellec CL, Lesniewska E, Giocondi MC, Finot E, Vié V, Goudonnet JP (1998) Imaging of the surface of living cells by low-force contact-mode atomic force microscopy. Biophys J 75:695-703
11. Hu W, Kavanagh JJ (2003) Anticancer therapy targeting the apoptotic pathway. Lancet Oncol 4:721-729
12. Huang GY, Zhang Y, Zhang Q, Zhang B, Wen LP (2010) Vacuolization and apoptosis induced by nano-selenium in HeLa cell line. Sci China Chem 53:2272-2278
13. Huang CH, Jin H, Song B, Zhu X, Zhao HX, Cai JY, Lu YJ, Chen B, Lin YC (2012) The cytotoxicity and anticancer mechanisms of alterporriol L, a marine bianthraquinone, against MCF-7 human breast cancer cells. Appl Microbiol Biotechnol 93:777-785
14. Jin H, Huang X, Chen Y, Zhao HX, Ye HY, Huang FC, Xing XB, Cai JY (2010) Photoinactivation effects of hematoporphyrin monomethyl ether on Gram-positive and -negative bacteria detected by atomic force microscopy. Appl Microbiol Biotechnol 88:761-770
15. Kalber TL, Kamaly N, So PW, Pugh JA, Bunch J, McLeod CW, Jorgensen MR, Miller AD, Bell JD (2011) A low molecular weight folate receptor targeted contrast agent for magnetic resonance tumor imaging. Mol Imaging Biol 13:653-662
16. Ke JH, Lin JJ, Carey JR, Chen JS, Chen CY (2010) A specific tumor-targeting magnetofluorescent nanoprobe for dual-modality molecular imaging. Biomaterials 31:1707-1715
17. Koller LD, Exon JH (1986) The two faces of selenium-deficiency and toxicity are similar in animals and man. Can J Vet Res 50:297-306
18. Kong L, Yuan Q, Zhu HR, Li Y, Guo QY (2011) The suppression of prostate LNCaP cancer cells growth by selenium nanoparticles through Akt/Mdm2/AR controlled apoptosis. Biomaterials 27:6515-6522
19. Laskey RA, Fairman MP, Blow JJ (1989) S phase of the cell cycle. Science 246:609-614
20. Leamon CP, Reddy JA (2004) Folate-targeted chemotherapy. Adv Drug Deliv Rev 56:1127-1141
21. Lee RJ, Wang S, Low PS (1996) Measurement of endosome pH following folate receptor-mediated endocytosis. BBA Mol Cell Res 1312:237-242
22. Lekka M, Laidler P (2009) Applicability of AFM in cancer detection. Nat Nanotechnol 4:72-73
23. Li GP, Li D, Zhang LX, Zhai JF, Wang E (2009) One-step synthesis of folic acid protected gold nanoparticles and their receptor-mediated intracellular uptake. Chem Eur J 15:9868-9873
24. Li Q, Chen TF, Yang F, Liu J, Zheng WJ (2010) Facile and controllable one-step fabrication of selenium nanoparticles assisted by L-cysteine. Mater Lett 64:614-617
25. Li YH, Li XL, Wong YS, Chen TF, Zhang HB, Liu CR, Zheng WJ (2011a) The reversal of cisplatin-induced nephrotoxicity by selenium nanoparticles functionalized with 11-mercapto-1-undecanol by inhibition of ROS-mediated apoptosis. Biomaterials 32:9068-9076
26. Li W, Zhao LN, Wei TT, Zhao YL, Chen CY (2011b) The inhibition of death receptor mediated apoptosis through lysosome stabilization following internalization of carboxyfullerene nanoparticles. Biomaterials 32:4030-4041
27. Lu M, Bi CS, Gong XG, Chen HM, Sheng XH, Deng TL, Xu KD (2007) Anti-proliferative effects of recombinant iron superoxide dismutase on HepG2 cells via a redox-dependent PI3k/Akt pathway. Appl Microbiol Biotechnol 76:193-201
28. Milosavljevic T, Kostic-Milosavljevic M, Jovanovic I, Krstic M (2002) Gastrointestinal and liver tumors and public health in Europe. Eur Rev Med Pharmacother 1:11-15
29. Muller RH, Jacobs C (2002) Buparvaquone mucoadhesive nanosuspension: preparation optimisation and long-term stability. Int J Pharm 237:151-161
30. Pan J, Feng SS (2008) Targeted delivery of paclitaxel using folate-decorated poly-(lactide)-vitamin E TPGS nanoparticles. Biomaterials 29:2663-2672
31. Patil JB, Kim J, Jayaprakasha GK (2010) Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway. Eur J Pharmacol 645:70-78
32. Qiu Y, Liu Y, Wang LM, Xu LG, Bai R, Ji YL, Wu XC, Zhao YL, Li YF, Chen CY (2010) Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 31:7606-7619
33. Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li XY, Tolliday NJ, Golub TR, Carr SA, Shamji AF, Stern AM, Mandinova A, Schreiber SL, Lee SW (2011) Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475:231-234
34. Rayman MP (2000) The importance of selenium to human health. Lancet 356:233-241
35. Reid ME, Duffield-Lillico AJ, Garland L, Turnbull BW, Clark LC, Marshall JR (2002) Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers 11:1285-1291
36. Rock C, Moos PJ (2009) Selenoprotein P regulation by the glucocorticoid receptor. Biometals 6:995-1009
37. Stéphanie L, Bénédicte C, Vincente LV, Katharina G, Corinne DL, Karine BL, Laure L, Dominique M, Minh-Dung N, Sara G, Brice D, Gérard Z, Florence J (2011) Evaluation of current practice: management of chemotherapy-related toxicities. Anti Cancer Drugs 9:919-925
38. Sudimack J, Lee RJ (2000) Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 41:147-162
39. Tabassum A, Bristow RG, Venkateswaran V (2010) Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: a good thing? Cancer Treat Rev 3:230-234
40. Tang HL, Le AHP, Lung HL (2006) The increase in mitochondrial association with actin precedes Bax translocation in apoptosis. Biochem J 396:1-5
41. Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H, Chiao PJ, Achanta G, Arlinghaus RB, Liu JS, Huang P (2006) Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate. Cancer Cell 10:241-252
42. Wang H, Zhang JS, Yu HQ (2007) Elemental selenium at nano size possesses lower toxicity without compromising the fundamental effect on selenoenzymes: comparison with selenomethionine in mice. Free Radic Biol Med 42:1524-1533
43. Wang HJ, Zhao PQ, Liang XF, Gong XQ, Song T, Niu RF, Chang J (2010) Folate-PEG coated cationic modified chitosan-cholesterol liposomes for tumor-targeted drug delivery. Biomaterials 31:4129-4138
44. Wang LM, Liu Y, Li W, Jiang XM, Ji YL, Wu XH, Xu LG, Qiu Y, Zhao K, Wei TT, Li YF, Zhao YL, Chen CY (2011a) Selective targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapy. Nano Lett 11:772-780
45. 2+ concentration. Eur J Pharmacol 650:41-47
46. Waterhouse NJ, Goldstein JC, Ahsen OV, Schuler M, Ne DD (2001) Cytochrome c maintains mitochondrial transmem-brane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J Cell Biol 153:319-328
47. Xia YY (2007) Synthesis of selenium nanoparticles in the presence of silk fibroin. Mater Lett 61:4321-4324
48. Yoo HS, Park TG (2004) Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J Control Release 2:247-256
49. Zhang Y, Kohler N, Zhang MQ (2002) Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 23:1553-1561
50. Zhang ZP, Lee SH, Feng SS (2007) Folate-decorated poly- (lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials 28:1889-1899
51. Zheng JS, Zheng SY, Zhang YB, Yu B, Zheng WJ, Yang F, Chen TF (2011) Sialic acid surface decoration enhances cellular uptake and apoptosis-inducing activity of selenium nanoparticles. Colloid Surf B 83:183-187